- Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis. Goss, C.H., McKone, E.F., Mathews, D., Kerr, D., Wanger, J.S., Millard, S.P. J. Cyst. Fibros. (2008)